𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Promoter CpG hypermethylation and downregulation of DICE1 expression in prostate cancer

✍ Scribed by Röpke, Albrecht; Buhtz, Peter; Böhm, Malte; Seger, Jeannette; Wieland, Ilse; Allhoff, Ernst P; Wieacker, Peter F


Book ID
110069867
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
301 KB
Volume
24
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Promoter hypermethylation in circulating
✍ Morgan Rouprêt; Vincent Hupertan; James W.F. Catto; David R. Yates; Ishtiaq Rehm 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB

## Abstract Promoter hypermethylation of circulating cell DNA has been advocated as a diagnostic marker for prostate cancer, but its prognostic use is currently unclear. To assess this role, we compared hypermethylation of circulating cell DNA from prostate cancer patients with (Group 1, __n__ = 20

CpG hypermethylation of promoter region
✍ Leopoldo Alves Ribeiro-Filho; Joseph Franks; Masahiro Sasaki; Hiroaki Shiina; Lo 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB

## Abstract Several studies have shown that E‐cadherin expression is lost during malignant transformation. We hypothesized that CpG methylation in the promoter region may inactivate the expression of the E‐cadherin gene in human bladder cancer. Normal and bladder cancer samples from 51 patients wer

Ethnic group-related differences in CpG
✍ Hideki Enokida; Hiroaki Shiina; Shinji Urakami; Mikio Igawa; Tatsuya Ogishima; D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 451 KB 👁 2 views

## Abstract The incidence and mortality of prostate cancer (PC) is approximately 2‐fold higher among African‐Americans as compared to Caucasians and very low in Asian. We hypothesize that inactivation of __GSTP1__ genes through CpG methylation plays a role in the pathogenesis of PC, and its ability